The mechanism for regulating interferon production was investigated in relation to accentuation of production in serum-free human diploid cells (strain WI-38) treated with N ~, O2-dibutyryl guanosine 3', 5'-cY clic monophosphate (dbcyclic GMP).
INTRODUCTION
To obtain interferon preparations with a high initial specific activity, it would be advantageous to omit serum from the culture medium during the period of interferon production. However, interferon production in human diploid cells and human leucocytes requires the presence of serum in media to yield substantial quantities of interferon (Hadhfizy et al. I969; Strander, i969; Billiau, et al. I972; Havell & Vil~ek, I972) . Our previous studies (Azuma et al. I978 ) have shown that pre-treatment of serum-flee human diploid cell cultures with insulin considerably increases the amount of interferon produced. Otten et al. (I972), Rozengurt & Jimenez de Asua (I973), and Rudland et al. (I974a) showed that insulin improved the growth of fibroblasts, and increased the amount of guanosine 3', 5'-cyclic monophosphate (cyclic GMP) and activity of guanyl cyclase in the cells, whereas the amount of adenosine 3',5'-cyclic monophosphate (cyclic AMP) was reduced. Dianzani et al. (I972) , and Reizin et al. (I975) showed that exogenous cyclic AMP inhibited interferon production. These observations raise the possibility that endogenous cyclic GMP may act as the intracellular mediator of some of the effects of insulin. If so, then it might be possible to demonstrate experimentally that cyclic GMP, introduced exogenously, accentuates interferon production in serum-free human diploid cell cultures: we show here that it does and we have investigated the possible mechanisms. 
METHODS

Materials
. N ~, O2-dibutyryl guanosine 3',5'-cyclic monophosphate (sodium salt; dbcyclic GMP) and insulin (24. 3 International units (i.u.)/mg, from bovine pancreas) were purchased from Sigma Chemical Co., Miss. U.S.A. Actinomycin D was obtained from Schwarz-Mann Research Labs, N.Y., U.S.A.: at a concentration of 0"5 #g/m1, it inhibited cellular RNA synthesis by 92% and also completely inhibited interferon synthesis in WI-38 cells in response to NDV. Cycloheximide was obtained from Nakarai Chemical Ltd, Kyoto: at 50 #g/ml, it inhibited cellular protein synthesis by 95 ~o. 5 -SH-uridine (I5 Ci/mmol) and U-14C-L-leucine (312 mCi/mmol) were purchased from The Radiochemical Centre, Amersham, England. Eagle's minimum essential medium (MEM) and Ham's FIo medium (FIO) were obtained from Nissui'Seiyaku Co., Tokyo.
Cell cultures. Human embryonic lung diploid cells (strain WI-38 ) were cultivated in MEM supplemented with IO% foetal bovine serum (MEM-FSto%). Serum-free cultures were prepared as follows: confluent monolayer cultures were washed three times with o.oi Mphosphate buffered saline solution (PBS), and replenished with serum-flee FIO. After 24 to 36 h of cultivation, the cultures were washed twice with PBS again, and used as serum-free cell cultures.
Viruses. A stock of the Miyadera strain of Newcastle disease virus (NDV) and the Indiana strain of vesicular stomatitis virus (VSV) were prepared as described previously (Azuma, I973) .
Interferon production and titration. WI-38 cell cultures were induced with NDV at a multiplicity of IOO p.f.u./cell. After 2 h of incubation, the cultures were washed twice with PBS, and re-fed with maintenance medium. Culture fluids were harvested I2 or I6 h after induction, mixed with an equal volume of anti-NDV rabbit serum (i28 haemagglutinationinhibiting units/ml), and incubated for I h at 37 °C, then overnight at 4 °C to inactivate NDV in the interferon samples. Interferon was assayed by the method of c.p.e, reduction in VSV-infected WI-38 cells described previously (Azuma, 1976 ) . The human reference standard interferon (Reagent number G-o23-9oi-517, U.S. National Institutes of Health), with an assigned potency of 20000, had a titre of I2800 by our method.
Cyclic GMP assay. Cell cultures treated with insulin at a dose of IOO #g/ml for various periods at 37 °C were immediately heated at 8o °C for 3o s, and then scraped off the dish, and disrupted in a Kontes ultrasonic cell disruptor (Kontes, N.J., U.S.A.) at full power for I min at 4 °C. Homogenized samples were centrifuged to remove insoluble components, and the supernatant fluids were lyophilized. The residues were dissolved in distilled water and centrifuged again to remove insoluble materials. The supernatant fluids were assayed for cyclic GMP, using a cyclic GMP assay kit (Yamasa Shoyu Institute, Choshi, Japan) as follows: for succinylation of cyclic GMP in the supernatant fluids, IOO #1 of samples were mixed with 5o #1 of succinylating reagent (mixture of 9 vol. of o'44 M-SUccinic anhydride in dioxane and I vol. of triethylamine). After IO rain of incubation at room temperature, 35o #1 of o'3 M-imidazole buffer were added to each mixture. One hundred #I of the succinylated samples were mixed with IOO #1 of 12~I-2'-O-succinyl cyclic GMP tyrosine methyl ester solution (125I-ScGMP-TME), and then IOO #1 of anti-cyclic GMP rabbit serum were added. After 12 h of incubation at 4 °C, 5oo #1 of dextran-coated charcoal suspension were added and mixtures were centrifuged at 3ooo g for 5 rain. Radioactivity in the supernatant fluid was counted in a LKB-Wallac IZ8O UltroGamma counter. The binding ratio of I~sI-ScGMP-TME to antibody was calculated, and the cyclic GMP content was estimated from the binding ratio and a standard curve. An equal volume of I N-NaOH was added to other samples of cell homogenates, which were hydrolysed by incubation at 70 °C for I h. The optical extinction at 28o nm was measured in a Shimazu UV-2oo spectrophotometer.
Pulse-labelling experiment. Serum-free and serum-containing cultures were replenished with L-leucine-free MEM and L-leucine-free MEM supplemented with 5 % dialysed FS, respectively, both media containing 2 #Ci/ml of 5-3H-uridine and o.2 #Ci/ml of U-14C-Lleucine. After 30 rain of incubation at 37 °C, the cultures were chilled in an ice-bath and washed three times with cold PBS. The cells were scraped off the dish and disrupted in a Kontes ultrasonic disruptor at full power for I min at 4 °C. Samples of homogenates were mixed with an equal volume of cold IO % (w/v) TCA. The precipitates were washed with cold 5 % (w/v) TCA on glass fibre filter paper (Whatman, GF/C), and the acid-insoluble radioactivity retained on the filter paper was measured in a Packard 156o Tri-Carb liquid scintillation spectrometer. Other samples of the cell homogenates were hydrolysed with I N-NaOH and the extinction at 28o nm was measured.
RESULTS
Effect of insulin treatment on the cyclic GMP content of WI-38 cells
In our previous studies (Azuma et al. I978) , insulin enhanced interferon production in WI-38 cells maintained in serum-free medium. Rudland et al. 0974a) reported that insulintreated fibroblasts showed an early and transient increase of intracellular cyclic GMP. We examined whether serum-free WI-38 cells treated with insulin also show an increase of intracellular cyclic GMP. Table I shows that the level increased after treatment with insulin.
Interferon production in serum-free WI-38 cell cultures treated with exogenous db-cyclic GMP
Serum-free cultures were re-fed with Fro supplemented with graded levels of db-cyclic GMP. After 2 h of incubation, cultures were induced with NDV in the presence of dbcyclic GMP for 2 h, washed with PBS and then replenished with the same medium containing db-cyclic GMP. Interferon was measured in samples taken I2 h after induction. The results presented in Table z show that db-cyclic GMP at a concentration of o.2 mM led to about an eightfold increase in the yield of interferon.
The enhancement of interferon production was not due to an extension of the production period, but to a net increase in the interferon yield during the same period (Fig. 0. In the following experiments, db-cyclic GMP at a concentration of 0-2 mM was used.
Effect of db-cyclic GMP on adsorption and growth of NDV
An experiment was performed to determine whether the presence of db-cyclic GMP increased the adsorption or growth of NDV in WI-38 cells, so that the virus functioned as a more effective inducer. No difference was found in the rate of adsorption (data not shown) or in the yield of infective particles and haemagglutinins (Fig. 2) .
RNA and protein synthesis in WI-38 cells cultured with or without serum
In order to obtain some information on the synthesis of macromolecules in serum-free and serum-containing WI-38 cells, their incorporation of 5-3H-uridine and U-14C-L-leucine into acid-insoluble fractions was compared. As shown in Table 3 , incorporation of5-3H-uridine in serum-free cells was greatly reduced compared with that in serum-containing cells, whereas there was no difference in the rate at which U-14C-L-leucine was incorporated into the acid-insoluble fraction.
I. YOSHIDA AND OTHERS * Serum-free cultures were treated with F1o or FIo containing graded levels of db-cyclic GMP from 2 h before induction to the time when interferon was measured.
t NDV was used at a multiplicity of Ioo p.f.u./cell. When serum-free cell cultures were treated with o.2 mM-db-cyclic GMP for 2 h, synthesis of both RNA and protein increased (Table 4) .
Mechanism of enhancement of interferon production by db-cyclie GMP
The data in Tables 3 and 4 suggest that decreased interferon production in serum-free WI-38 cells results from a decreased synthesis of interferon messenger RNA and that treat- ment of the cells with db-cyclic GMP increases interferon messenger RNA synthesis and hence interferon production. Weinstein et al. (I974) observed that cyclic GMP and its derivatives stimulated RNA and DNA synthesis in lymphocytes. Therefore, we examined whether rib-cyclic GMP, introduced exogenously, accentuated the synthesis of actual interferon messenger RNA.
One of two sets of duplicate serum-free cultures was treated with o.2 mM-db-cyclic GMP for z h at 37 °C and the other set was left untreated. All cultures were then induced with NDV for 2 h at 37 °C. After removal of the virus and washing of the cultures, cycloheximide at a concentration of 5o #g/ml was added for 5 h to accumulate interferon messenger RNA, and o'5 #g/ml of actinomycin D was added for 3o rain to inhibit further transcription of the interferon gene. The cultures were washed three times with PBS and replenished with FIo.
Interferon titres were measured 23 h after induction. The results presented in Fig. 3 show that db-cyclic GMP treatment augmented interferon production and suggests that db-cyclic GMP treatment enhances transcription of the interferon gene.
DISCUSSION
Human diploid cells cultivated in serum-free medium produce a reduced amount of interferon (Havell & Vil~ek, I972; Azuma et al. I978) . Results of the present studies show that RNA synthesis is greatly reduced in such cell cultures, whereas protein synthesis continues normally, and that db-cyclic GMP, introduced exogenously, accentuates RNA synthesis, in agreement with an earlier report (Weinstein et al. ~974) . The present data also demonstrate that pre-treatment of serum-free cell cultures with db-cyclic GMP enhances the amount of interferon produced. Recent reports (Dianzani et al. I972; Reizin et aL I975) showed that rib-cyclic AMP inhibited interferon production. These findings do not directly show what processes trigger interferon induction, but one may assume that interferon induction is regulated by cyclic GMP in a positive direction and by cyclic AMP in a negative direction, as well as by such other events as cell growth (Seifert & Paul, 1972; Rudland et al. I974b) , RNA and DNA synthesis (Weinstein et al. I974) , and enzyme secretion (Bdolach & Schramm, I965) .
It is possible that the effects of cyclic GMP which we have observed may occur normally in vivo, but it should be noted that the concentrations of rib-cyclic nucleotides used in our study were high and non-physiological. However, data in Table I show that the cyclic GMP level increased in the fmol range when serum-free WI-38 cells were treated with insulin, and interferon production in such cells was enhanced (Azuma et al. I978) . These observations suggest that a very small amount of db-cyclic GMP introduced exogenously does actually permeate the cells and produce physiological effects. We observed that dbcyclic GMP at a concentration of o.2 mM boosted interferon production, but at a concentration of I mM, the increase was less (Table 2 ). This latter result may reflect the toxic action of butyric acid derived from db-cyclic GMP: in a preliminary experiment (data not shown), butyric acid at a concentration of I mM depressed the production of interferon by serum-free WI-38 cells in response to NDV.
In contrast with our results, Soeiro & Amos 0966) reported that chick embryo cells deprived of serum synthesized protein at a reduced rate. Hadhfizy et al. 0969) demonstrated that translation of interferon messenger RNA was reduced when leucocytes were incubated in serum-free medium, thereby causing a low yield of interferon. We cannot explain these discrepancies at present, but presumably they reflect the different cells involved.
In a previous report (Azuma, I976) , it was suggested that interferon was induced by a factor or factors present up to the uncoating step of NDV. The present studies have shown that cyclic GMP, introduced exogenously, does not affect NDV growth in WI-38 cells. A possible interaction between activation of the interferon gene by cyclic GMP and factor(s) present up to the uncoating step of NDV, or other inducers should therefore be examined.
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